ZYXI ZYNEX INC

Nasdaq zynex.com


$ 1.32 $ -0.01 (-0.75 %)    

Friday, 17-Oct-2025 15:59:40 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 1.33
$ 1.36
$ 1.30 x 15
$ 1.42 x 15
$ 1.30 - $ 1.37
$ 1.23 - $ 9.42
101,325
na
40.3M
$ 1.24
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2025 06-30-2025 10-Q
2 04-29-2025 03-31-2025 10-Q
3 03-11-2025 12-31-2024 10-K
4 10-24-2024 09-30-2024 10-Q
5 07-25-2024 06-30-2024 10-Q
6 04-30-2024 03-31-2024 10-Q
7 03-12-2024 12-31-2023 10-K
8 10-26-2023 09-30-2023 10-Q
9 07-27-2023 06-30-2023 10-Q
10 04-27-2023 03-31-2023 10-Q
11 03-14-2023 12-31-2022 10-K
12 10-27-2022 09-30-2022 10-Q
13 07-28-2022 06-30-2022 10-Q
14 04-28-2022 03-31-2022 10-Q
15 03-21-2022 12-31-2021 10-K
16 11-02-2021 09-30-2021 10-Q
17 07-29-2021 06-30-2021 10-Q
18 04-29-2021 03-31-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 10-27-2020 09-30-2020 10-Q
21 07-28-2020 06-30-2020 10-Q
22 04-28-2020 03-31-2020 10-Q
23 02-27-2020 12-31-2019 10-K
24 10-29-2019 09-30-2019 10-Q
25 07-31-2019 06-30-2019 10-Q
26 04-30-2019 03-31-2019 10-Q
27 02-26-2019 12-31-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-08-2018 03-31-2018 10-Q
31 02-28-2018 12-31-2017 10-K
32 11-13-2017 09-30-2017 10-Q
33 08-14-2017 06-30-2017 10-Q
34 05-26-2017 03-31-2017 10-Q
35 04-17-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
37 08-23-2016 06-30-2016 10-Q
38 05-20-2016 03-31-2016 10-Q
39 03-31-2016 12-31-2015 10-K
40 11-17-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 zynex-terminated-positions-of-a-majority-of-zms-employees-to-seek-commercialization-partner-for-nico-co-oximeter-rather-than-pursue-commercialization-independently

https://www.sec.gov/Archives/edgar/data/846475/000110465925097588/zyxi-20251001x8k.htm

 hc-wainwright--co-downgrades-zynex-to-neutral

HC Wainwright & Co. analyst Yi Chen downgrades Zynex (NASDAQ:ZYXI) from Buy to Neutral.

 update-zynex-q2-adj-eps-032-misses-020-estimate-sales-2229m-miss-2738m-estimate

Zynex (NASDAQ:ZYXI) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.20) by 62...

 zynex-dan-moorhead-resigns-as-cfo--effective-august-29-2025

-SEC Filing

 rbc-capital-maintains-sector-perform-on-zynex-lowers-price-target-to-3

RBC Capital analyst Shagun Singh maintains Zynex (NASDAQ:ZYXI) with a Sector Perform and lowers the price target from $4 to $3.

 hc-wainwright--co-reiterates-buy-on-zynex-maintains-8-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Zynex (NASDAQ:ZYXI) with a Buy and maintains $8 price target.

 zynex-announces-steven-dyson-as-new-ceo-effective--august-18-2025

 Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in noninvasive medical devices for pain manag...

 zynex-executes-workforce-reduction-affecting-86-corporate-roles-expects-5m-in-annualized-cost-savings-from-workforce-reduction-awaits-response-to-appeal-on-tricare-payment-suspension

https://www.sec.gov/Archives/edgar/data/846475/000155837025008834/zyxi-20250618x8k.htm

 mellingmedical-teams-up-with-zynex-medical-to-expand-access-to-non-invasive-pain-management-solutions-across-federal-healthcare-system

Strategic agreement brings innovative electrotherapy and orthotic solutions to America's veterans, active duty and DoD pers...

 zynex-submits-510k-application-to-fda-for-nico-noninvasive-co-oximeter-device

Zynex, Inc. (NASDAQ:ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive me...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION